1887

Abstract

Production of toxins A and B by is enhanced in a defined medium with biotin-limited conditions. In the present study compounds inhibitory to enhanced toxin production by a strain were examined. Increases in biotin concentration from 0.05 nM to 50 nM accelerated growth and inhibited enhanced toxin production. Asparagine, glutamic acid and glutamine (10 mM) showed an effect on growth and toxin production similar to that of biotin. Lysine (10 mM) suppressed growth and inhibited toxin production. Addition of these toxin-inhibitory compounds within an incubation period of 2 days inhibited the enhanced toxin production, but later addition showed only slight inhibition of toxin production. Amino acids contained in the defined medium under the biotin-limited conditions were actively utilised in the presence of the three toxin-inhibitory amino acids, but in the presence of lysine, amino-acid utilisation was suppressed. Different mechanisms of action of these toxin-inhibitory molecules, which may be divided into excess biotin, asparagine-glutamic acid-glutamine group, and lysine, are discussed.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-47-9-767
1998-09-01
2022-08-17
Loading full text...

Full text loading...

/deliver/fulltext/jmm/47/9/medmicro-47-9-767.html?itemId=/content/journal/jmm/10.1099/00222615-47-9-767&mimeType=html&fmt=ahah

References

  1. Lyerly D. M., Krivan H. C., Wilkins T. D. Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1988; 1:1–18
    [Google Scholar]
  2. Dove C. H., Wang S.-Z., Price S. B. Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun 1990; 58:480–488
    [Google Scholar]
  3. Johnson J. L., Phelps C., Barroso L., Roberts M. D., Lyerly D. M., Wilkins T. D. Cloning and expression of the toxin B gene of Clostridium difficile. Curr Microbiol 1990; 20:397–401
    [Google Scholar]
  4. Just I., Wilm M., Selzer J. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem 1995; 270:13932–13936
    [Google Scholar]
  5. Just I., Selzer J., Wilm M., von Eichel-Streiber C., Mann M., Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 1995; 375:500–503
    [Google Scholar]
  6. Yamakawa K., Karasawa T., Ikoma S., Nakamura S. Enhancement of Clostridium difficile toxin production in biotin-limited conditions. J Med Microbiol 1996; 44:111–114
    [Google Scholar]
  7. Lehninger A. L., Nelson D. L., Cox M. M. Principles of biochemistry. 2nd edn New York: Worth Publishers; 1993
    [Google Scholar]
  8. Yamakawa K., Kamiya S., Meng X. Q., Karasawa T., Nakamura S. Toxin production by Clostridium difficile in a defined medium with limited amino acids. J Med Microbiol 1994; 41:319–323
    [Google Scholar]
  9. Haslam S. C., Ketley J. M., Mitchell T. J., Stephen J., Burdon D. W., Candy D. C. A. Growth of Clostridium difficile and production of toxins A and B in complex and defined media. J Med Microbiol 1986; 21:293–297
    [Google Scholar]
  10. Karasawa T., Ikoma S., Yamakawa K., Nakamura S. A defined growth medium for Clostridium difficile. Microbiology 1995; 141:371–375
    [Google Scholar]
  11. Kamiya S., Ogura H., Meng X. Q., Nakamura S. Correlation between cytotoxin production and sporulation in Clostridium difficile. J Med Microbiol 1992; 37:206–210
    [Google Scholar]
  12. Patterson-Curtis S. I., Johnson E. A. Regulation of neurotoxin and protease formation in Clostridium botulinum Okra B and Hall A by arginine. Appl Environ Microbiol 1989; 55:1544–1548
    [Google Scholar]
  13. Leyer G. J., Johnson E. A. Repression of toxin production by tryptophan in Clostridium botulinum type E. Arch Microbiol 1990; 154:443–447
    [Google Scholar]
  14. Andreesen J. R., Bahl H., Gottschalk G. Introduction to the physiology and biochemistry of the genus Clostridium. In Minton N. P., Clarke D. J. (eds) Clostridia New York: Plenum Press; 198927–62
    [Google Scholar]
  15. Braun V., Hundsberger T., Leukel P., Souerbom M., von Eichel-Streiber C. Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 1996; 181:29–38
    [Google Scholar]
  16. Hammond G. A., Lyerly D. M., Johnson J. L. Transcriptional analysis of the toxigenic element of Clostridium difficile. Microb Pathog 1997; 22:143–154
    [Google Scholar]
  17. Hundsberger T., Braun Y., Weidmann M., Leukel P., Sauerbom M., von Eichel-Streiber C. Transcription analysis of the genes tcdA –E of the pathogenicity locus of Clostridium difficile. Eur J Biochem 1997; 244:735–742
    [Google Scholar]
  18. Moncrief J. S., Barroso L. A., Wilkins T. D. Positive regulation of Clostridium difficile toxins. Infect Immun 1997; 65:1105–1108.m
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-47-9-767
Loading
/content/journal/jmm/10.1099/00222615-47-9-767
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error